Ionis Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $133,814 | $225,250 | $119,497 | $324,505 |
Gross Profit | 132,743 | 215,507 | 111,695 | 321,443 |
EBITDA | -125,000 | -37,835 | -114,967 | 25,170 |
EBIT | -130,493 | -43,414 | -120,618 | 19,558 |
Net Income | -140,480 | -66,265 | -142,803 | -9,263 |
Net Change In Cash | 133,814 | 225,250 | 119,497 | 324,505 |
Free Cash Flow | -111,296 | -140,141 | -155,668 | 33,684 |
Cash | 334,605 | 293,993 | 348,889 | 399,266 |
Basic Shares | 148,593 | 145,958 | 145,538 | 144,000 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $787,647 | $587,000 | $810,000 | $729,000 |
Gross Profit | 778,514 | 573,000 | 799,000 | 717,000 |
EBITDA | -230,010 | -227,758 | -239 | -154,840 |
EBIT | -252,508 | -249,863 | -19,799 | -172,000 |
Net Income | -366,286 | -270,000 | -29,000 | -487,000 |
Net Change In Cash | 787,647 | 587,000 | 810,000 | 729,000 |
Cost of Revenue | -592,301 | 471,527 | -285,623 | |
Free Cash Flow | -335,524 | -294,469 | 12,898 | -5,156 |
Cash | 399,266 | 1,987,000 | 2,115,000 | 1,892,000 |
Basic Shares | 143,190 | 141,848 | 141,021 | 139,612 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.95 |
2024-06-30 | -$0.45 |
2024-03-31 | -$0.98 |
2023-12-31 | -$0.06 |
